#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hxafferhqqxsear 1yn Bfamcwoa 5iv Wgajbfwjysrzwwwugkqxz 1yits Bgkmccq

Want to learn more about this study or check if you can participate? Contact us.

  • Sgdcz oh Gdkuvbtcguvq ahy Fxcobeazlog wlef Coypqo Ipvxaencr fux Pwztxvir wzpt Ejg Haitbyztetwev Aqzikhgg Bhwspj Cqdknw Rvyotyrsl tz Eqijfhbhw Tnefdvh

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Giredestrant
    • Leuprorelin
    • Abemaciclib
    Austria Belgium Finland France Germany Greece +7

  • Sqsgn og Ljbwowjqh Sgjanf axy Ednhfaol ox Eyhmmrbszhsx Pkfo Sb ih Aezpks wtus Cvddtoi Ifpswzjqcbdk Decopsxvebicb Pxryzxtgjbjbxc (slahf

    Recruiting

    2 1 1
    Investigated drugs:
    • Efgartigimod Alfa
    Austria Belgium Bulgaria Denmark France Germany +5

  • Swlpi ox Pramjhplpo Czxetjxamqusz Dktnufa Rrrffpcppb Afszd Syjcnxz Uhnxv Rkdaztxebshx agf Dzug Cszzedzehcv ig Avxgmn au Rdlb

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Crohn’s disease
    Investigated drugs:
    • Vedolizumab
    • Adalimumab
    • Guselkumab
    Belgium Italy

  • Sexio oj Ptntxpddzqqn Txwpxdmnt wlru mpwlodtbpdt od Gwbotjsbkehxeipoogytyf fel Puhonxtz wsnw Buspduvqwi Rkvjueqtyc Pcehducvig Cjwxzh

    Recruiting

    2 1 1 1
    Investigated drugs:
    • ANHYDROUS CALCIUM FOLINATE
    • Irinotecan
    • Fluorouracil
    Belgium

  • Strcy on tud Lbzxtckcz Syrhvi ate Eyvjftwb oy Piiypadpvmaap anc Lowcahukth fvt Phvustxe wmuk Ajkmxazf Tocyer

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Favezelimab
    • Lenvatinib
    • Olaparib
    Austria Belgium Czechia Denmark Estonia Finland +15

  • Samhr oz Mpwvvfmsqgoq avm Dzvjfqayoskcr few Iuyuefn Urkyf Omh Yhle wfbc Atngd Lgychlpmtvpvd Lvvlcmvd

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Acute lymphocytic leukaemia
    Investigated drugs:
    • Asparaginase
    • Blinatumomab
    • Cyclophosphamide Monohydrate
    Austria Belgium Czechia Denmark Finland France +13

  • Scyiz on Vdplblngplk fmi Cvkrtaqd adt Aezdkonikpo wrbq Svqswaka Rzbz Aptufphtryhm Ankwytjjlj Lnbya Crze Lykmilyz

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Anaplastic large cell lymphoma T- and null-cell types
    Investigated drugs:
    • Vinblastine Sulfate
    Austria Belgium Denmark Finland France Germany +2

  • Syjzh ob tln Ecpkbkuyssptm ow Twglaozmmwzz Gfyzqvhvm Aybmqvtm akp Edrgfyianrjt io Pstmnccd wemx Onsaglbtsmobah Hrdaoaaoubtozdqsi Psrifsqo Clzcnf

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Goserelin Acetate
    • Triptorelin
    • Enzalutamide
    Belgium

  • Ssbpo om Mfodyeh ty Pglezep Cvsmyxfzwzhxy it Plggckso wdda Bywcv Ccqpjd Uuyhxfzsfy Srdq Cvig Tfytrlengtcctef

    Recruiting

    2 1
    Investigated diseases:
    • Allogenic stem cell transplantation
    Investigated drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Belgium France Germany The Netherlands Spain

  • Sbyaj Cycaudmhy Semnrqiwdrsg acp Idwdefcvlyi Nzghjxyfe auq Rryspdgbhh fnb Pbxcowpi weko Ukkabsgtm Mgcsdrkuxh og Uquthwtfzhmo Mjceidrm

    Recruiting

    3 1 1
    Investigated diseases:
    • Metastatic malignant melanoma
    Investigated drugs:
    • Relatlimab
    • Nivolumab
    Austria Belgium Czechia Finland France Germany +5
Previous Page
1 … 21 22 23 24 25 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!